VC
APTO

Voss Capital’s Aptose Biosciences, Inc. APTO Stock Holding History

Voss Capital’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-488
Closed -$67.9K – 50
2023
Q2 		$67.9K Sell
488
-734
-60% -$152K 0.01% 46
2023
Q1 		$352K Hold
1,222
– – 0.05% 37
2022
Q4 		$319K Sell
1,222
-111
-8% -$29.8K 0.06% 42
2022
Q3 		$357K Sell
1,333
-223
-14% -$76.9K 0.1% 40
2022
Q2 		$519K Buy
1,556
+334
+27% +$160K 0.17% 32
2022
Q1 		$748K Hold
1,222
– – 0.24% 35
2021
Q4 		$743K Buy
1,222
+1,072
+715% +$1.01M 0.23% 34
2021
Q3 		$147K Sell
150
-784
-84% -$981K 0.06% 33
2021
Q2 		$1.4M Sell
934
-44
-4% -$95.9K 0.58% 29
2021
Q1 		$2.63M Sell
978
-611
-38% -$1.21M 1.1% 29
2020
Q4 		$3.13M Buy
1,589
+72
+5% +$169K 1.58% 23
2020
Q3 		$4.1M Buy
1,517
+617
+69% +$1.54M 2.34% 18
2020
Q2 		$2.56M Sell
900
-233
-21% -$752K 1.71% 16
2020
Q1 		$1.84M Buy
1,133
+454
+67% +$1.35M 2.46% 12
2019
Q4 		$1.73M Buy
+679
New +$885K 0.26% 58

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $733M AUM 11.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Voss Capital's APTO Position: Q3 2023 in Review

Voss Capital sold out of Aptose Biosciences, Inc. (APTO) in Q3 2023, closing a stake of 488 shares — an estimated $67.9K sold.

Voss Capital first reported a position in APTO in Q4 2019 and held it in 15 quarters. The position peaked at $4.1M in Q3 2020. 25 funds tracked by Wall St. Rank hold APTO as of Q3 2023.

  • Voss Capital reported no remaining Aptose Biosciences, Inc. position as of Q3 2023 after selling out during the quarter.
  • Voss Capital sold 488 Aptose Biosciences, Inc. shares in Q3 2023, an estimated $67.9K.
  • Voss Capital first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 15 quarters.
  • Voss Capital's Aptose Biosciences, Inc. position peaked at $4.1M in Q3 2020.
  • 25 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2023.

Based on Voss Capital's 13F filing for Q3 2023, filed 19 Oct 2023.